Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Hiromu Kondo"'
Autor:
Sorato Ikeda, Masanori Kobayashi, Soken Aoki, Takayuki Terukina, Takanori Kanazawa, Hiroyuki Kojima, Hiromu Kondo
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 395 (2023)
Three-dimensional printing technology holds marked promise for the pharmaceutical industry and is now under intense investigation. Most research is aimed at a greater efficiency in printing oral dosage forms using powder bed printing or fused deposit
Externí odkaz:
https://doaj.org/article/0cdfc5f076f643148f2321e6a50f1ee7
Autor:
Takumi Kurano, Takanori Kanazawa, Shingo Iioka, Hiromu Kondo, Yasuhiro Kosuge, Toyofumi Suzuki
Publikováno v:
Pharmaceutics, Vol 14, Iss 12, p 2590 (2022)
Intranasal administration is a promising route for direct drug delivery to the brain; its combination with nanocarriers enhances delivery. We have previously shown that intranasal administration combined with PEG-PCL-Tat (a nanocarrier) efficiently d
Externí odkaz:
https://doaj.org/article/d5dac02d506a4733803f8b18a9db572b
Autor:
Momoka Yamaguchi, Takanori Kanazawa, Sumire Morino, Shingo Iioka, Yuta Watanabe, Naoki Dohi, Kenjirou Higashi, Hiromu Kondo, Tomohisa Ishikawa
Publikováno v:
Membranes, Vol 12, Iss 10, p 1023 (2022)
Myofibroblast-like activated hepatic stellate cells (aHSCs), which produce collagen, a major cause of liver fibrosis, are specific target cells for antifibrotic treatment. Recently, several reports have indicated that extracellular vesicles (EVs) pla
Externí odkaz:
https://doaj.org/article/8a76f8485d744d63aeebf661505a22c0
Publikováno v:
International Journal of Pharmaceutics: X, Vol 1, Iss , Pp - (2019)
The aim of this study was to design and evaluate muco-adhesive orally disintegrating tablets manufactured by microwave irradiation and containing polysaccharide. We prepared orally disintegrating tea tablets (ODTTs) containing a 1 w/w% mass fraction
Externí odkaz:
https://doaj.org/article/1dfa34ffa950415ba810cf4f06ce6306
Autor:
Seira Matsuo, Kenjirou Higashi, Kunikazu Moribe, Shin-ichiro Kimura, Shigeru Itai, Hiromu Kondo, Yasunori Iwao
Publikováno v:
Nanomaterials, Vol 8, Iss 12, p 998 (2018)
To improve the solubility of the drug nifedipine (NI), NI-encapsulated lipid-based nanoparticles (NI-LNs) have been prepared from neutral hydrogenated soybean phosphatidylcholine and negatively charged dipalmitoylphosphatidylglycerol at a molar ratio
Externí odkaz:
https://doaj.org/article/4dcbda58dbdf4a92bdfc378ea8740e8c
Autor:
Yasuki Hori, Katsuyuki Miyabe, Michihiro Yoshida, Takahiro Nakazawa, Kazuki Hayashi, Itaru Naitoh, Shuya Shimizu, Hiromu Kondo, Yuji Nishi, Shuichiro Umemura, Akihisa Kato, Hirotaka Ohara, Hiroshi Inagaki, Takashi Joh
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0118829 (2015)
Single-nucleotide polymorphisms (SNPs) of TP53 (codon 72, rs1042522) and MDM2 promoter (SNP 309, rs2279744) have been associated with risk for various human cancers. However, studies analyzing these polymorphisms in pancreatic ductal adenocarcinoma (
Externí odkaz:
https://doaj.org/article/c27ba4599ac249f7bf29a58cd50b3899
Autor:
Takayuki Terukina, Jun Tanaka, Yumi Takayama, Kaede Osanai, Shusuke Kino, Takanori Kanazawa, Hiromu Kondo
Publikováno v:
Drug Development and Industrial Pharmacy. 49:75-83
Autor:
Yusuke Oe, Shinichi Ogino, Masanori Kobayashi, Hiroyuki Kojima, Takayuki Terukina, Takanori Kanazawa, Hiromu Kondo
Publikováno v:
Journal of Pharmaceutical Sciences. 111:2322-2329
The objective of this study was to develop a testosterone sustained release formulation for the treatment of fecal incontinence. To suppress the initial burst release of testosterone, which can lead to systemic toxicity, we incorporated a washing ste
Autor:
Takashi Joh, Satoru Takahashi, Aya Naiki-Ito, Akihiro Nomoto, Atsushi Narumi, Takashi Murakami, Makoto Natsume, Yasuki Hori, Yasuaki Fujita, Michihiro Yoshida, Hiromu Kondo, Katsuyuki Miyabe, Tesshin Ban, Itaru Naitoh, Mamoru Tanaka, Noriyuki Hayashi, Kazuki Hayashi, Shigenobu Yano, Hiromi Kataoka, Akihisa Kato
Supplementary Figure S1: Cell viability in pancreatic cancer cells treated by talaporfin with or without irradiation. Supplementary Figure S2: The luciferase luminescence intensities in AsPC1/luc cells treated by PDT with talaporfin or Mal3-chlorin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a2488c170b1a431b5f9af750aa831f
https://doi.org/10.1158/1535-7163.22504302.v1
https://doi.org/10.1158/1535-7163.22504302.v1
Autor:
Takashi Joh, Satoru Takahashi, Aya Naiki-Ito, Akihiro Nomoto, Atsushi Narumi, Takashi Murakami, Makoto Natsume, Yasuki Hori, Yasuaki Fujita, Michihiro Yoshida, Hiromu Kondo, Katsuyuki Miyabe, Tesshin Ban, Itaru Naitoh, Mamoru Tanaka, Noriyuki Hayashi, Kazuki Hayashi, Shigenobu Yano, Hiromi Kataoka, Akihisa Kato
Images of representative abdominal skin of mice from each group.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dac4c33f9d900b8169e8a48d46ff261
https://doi.org/10.1158/1535-7163.22504290.v1
https://doi.org/10.1158/1535-7163.22504290.v1